Quantamental Intelligence
We find stocks the market has priced wrong. Eight structured dimensions, one clear verdict. Independent research that tells you what to do — not just what happened.
Perception Gap
+2.60
Proprietary
Multi-Factor Signal Engine
100%
Independent: No bank, no fund
Adaptive
Monitoring Cadence
Deep Dive
Research Format
What Makes This Different
Every published analysis includes a Prescription section: specific operational, capital allocation, or structural changes that would materially shift our rating, with an estimated valuation impact range.
This makes our research useful to two audiences: investors who want to act on the gap, and management teams who want to close it.
How we score and prescribe →Example Prescription
Halt acquisitions for 18 months
Organic growth becomes visible at 6-7%. Compounder multiple becomes defensible.
+AUD 1.40 to +AUD 2.60Refinance 2026 debt at current rates
WACC reduces ~80bps. Interest coverage ratio improves to 4.2x.
+AUD 0.70 on fair value floorContinue current acquisition pace
Organic deterioration stays masked. Market re-rates toward sector median.
-AUD 1.50 to -AUD 2.20Illustrative. Full prescriptions for subscribers only.
Intelligence Platform
Last analysis: 2026-04-01 · Next review: adaptive
Quality Score
25/40
Gap Signal
+2.60
Signal Scorecard
Analyst Verdict
Market sentiment has overshot the fundamentals. The selloff reflects macro fears, not company-specific deterioration. Earnings quality is high, balance sheet is clean, and the moat is intact. At current pricing the market is handing you the premium for free.
Prescription
Initiate position in three tranches between €36 and €42. Set a thesis-change alert for Q3 margin data. Fair value range €48-57. Full prescription with four scenarios available to subscribers.
Intelligence tier required to view full analysis
Subscribe for Full AccessThe Framework
Every company is scored across the same structured framework, without gut feel or narrative bias. Each dimension has defined criteria and contributes directly to the composite rating.
01
Earnings Quality
Cash conversion, accruals, and the reliability of reported profits. High-quality earnings are backed by free cash flow, not accounting adjustments.
02
Business Model Strength
Structural durability of the revenue model. Recurring revenue, switching costs, and pricing power all factor into this dimension.
03
Competitive Moat
Depth and durability of competitive advantages. Network effects, intangibles, cost advantages, and market position are assessed.
04
Management & Capital Allocation
Track record of capital deployment: M&A discipline, buybacks, dividends, insider ownership, and shareholder alignment.
05
Balance Sheet Health
Leverage, liquidity, and financial resilience. Strong balance sheets survive downturns and allow opportunistic action.
06
Growth Trajectory
Revenue, margin, and free cash flow trends over time. We distinguish between structural growth and cyclical tailwinds.
07
Valuation vs. Fundamentals
Fair value derived from DCF, multiples, and peer comparisons. We calculate a range, not a false-precision point estimate.
08
Perception Gap
The delta between how the market prices the company and what the fundamentals justify. Wide gaps create asymmetric opportunities.
Access
One platform, three tiers. All include the same underlying intelligence.
Insights
For investors who want the thesis and scorecard overview without the full model.
Most Popular
Intelligence
Full platform access. Every dimension, every signal, every prescription.
Professional
For serious investors who need the full picture plus custom alerting.